Stock Market News & Stocks to Watch from StraightStocks » Malaria

GenVec’s TNFerade Nears NDA Status (NASDAQ:GNVC)

Michael Vlaicu — Wed, 09 Sep 2009 06:06:14 +0000

GenVec, Inc. (Public, NASDAQ:GNVC) StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product [...]

PennyOmega.com Stock Report! 8/26/09, RZ, TIBX, GDTI, NRPI, IRBS, OMTR

PennyOmega.com — Wed, 26 Aug 2009 12:39:42 +0000

<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<<

Bio-Solutions Corp. (BISU.OB) Adds Malaria Insecticide to Product Portfolio

QualityStocks — Mon, 13 Jul 2009 19:48:16 +0000

Bio-Solutions Corp. focuses on veterinary care and organic dietary supplements for livestock and domestic animals. The company announced last week it will market an organic insecticide to combat Malaria. GreenExTM is available in solid or liquid form, and works by neutralizing and eradicating up to 98 percent of mosquito larvae within a 24-hour period. Malaria [...]

Bill Gates Releases Mosquitoes at Conference

Fred Fuld — Thu, 05 Feb 2009 16:21:00 +0000

Bill Gates, founder of Microsoft (MSFT) a href="http://news.yahoo.com/s/afp/20090205/ts_alt_afp/usitinternethealthfinancegates" target="_blank"released a jar of mosquitoes/a at a conference to spread the word about malaria.div class="blogger-post-footer"div class='adsense' style='text-align:center; padding: 0px 3px 0.5em 3px;' script type="text/javascript"!-- google_ad_client="ca-pub-2427831169011625"; google_ad_width=300; google_ad_height=250; google_ad_format="300x250_as"; google_ad_type="text"; google_ad_channel ="8681602088"; google_color_border="FFF3DB"; google_color_bg="FFF3DB"; google_color_link="1B0431"; google_color_url="1B0431"; google_color_text="29303B"; //--/script script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js" /script /div

Quest for the City of Gold

Sean Brodrick — Wed, 03 Dec 2008 13:56:17 +0000

El Dorado ... Cibola ... Quivira ... these are all fabled "lost cities of gold" that fired up the imaginations of explorers who pursued their dreams to the four corners of the Earth. These cities only existed in the fevered imaginations of storytellers. But there was a ...

GenVec, Inc.’s (GNVC) TNFerade™ Gets FDA Fast Track Designation for Pancreatic Cancer Treatment

QualityStocks — Tue, 11 Nov 2008 19:19:06 +0000

GenVec, Inc. reported today that the U.S. Food and Drug Administration (FDA) has approved GenVec’s TNFerade™ for Fast Track development in the treatment of locally advanced pancreatic cancer. TNFerade™ is designed to stimulate the production of immune system proteins with anti-cancer properties that are injected into tumors. GenVec is developing TNFerade™ [...]

GenVec, Inc. (GNVC) Continues Funding Streak from NIAID for HIV Vaccine Research

QualityStocks — Fri, 03 Oct 2008 12:18:47 +0000

GenVec, Inc. (NASDAQ: GNVC) announced Thursday that it received a third year option of funding, as part of a five-year contract with the National Institute of Allergy and Infectious Disease. The company will receive up to $3.8 million to continue the development of new HIV vaccine candidates. GenVec’s research is based on its proprietary adenovirus [...]

Immtech Pharmaceuticals Inc. (IMM): Working on Cures for Rare Diseases and for Ailing Portfolios

QualityStocks — Wed, 24 Sep 2008 01:09:46 +0000

Immtech Pharmaceuticals (IMM) is an early stage biotechnology working on cures and treatments for infectious diseases such as African Sleeping Sickness and Pneumocystis pneumonia (PCP). While these diseases are rare in the developed world, they infect millions, if not billions, of people in the third world, meaning the market for Immtechs products could be nearly [...]

Sinobiomed Inc. (SOBM.OB): Chinese Wonder Drug-Maker?

QualityStocks — Sat, 06 Sep 2008 02:17:20 +0000

Sinobiomed (SOBM) is a Chinese developer of genetically engineered recombinant protein drugs and vaccines. The company’s drugs treat diseases and ailments such as malaria, hepatitis, surgical bleeding, cancer, rheumatoid arthritis, diabetic ulcers and burns, and blood cell regeneration. Sinobiomed currently has 10 products: three on the market, four in clinical trials and three in [...]

HotStix Stock of the Week – Sinobiomed Inc. (SOBM.OB)

QualityStocks — Tue, 26 Aug 2008 17:19:34 +0000

Sinobiomed Inc. (SOBM.OB) is a leading Chinese developer of genetically engineered recombinant protein drugs and vaccines. Sinobiomed employs a patented low-cost, high yield production process to enhance bioactivity and guarantee the highest levels of purity. Sinobiomed currently has 10 products approved or in development: three on the market, four in clinical trials, and three in R&D. [...]

Vaccine Trials, Uses, Progress for Sinobiomed, Inc. (SOBM.OB)

QualityStocks — Thu, 21 Aug 2008 12:10:46 +0000

Sinobiomed’s (OTCBB: SOBM) recombinant Batroxobin (rBAT) is in its Phase IIb trials for 328 patients. Results are expected before year’s end. A company news release says international interest from government and organizations would grow significantly if the product proceeds to Phase III clinical trials. “[We have] already received indications of interest from global pharmaceutical companies for [...]